Current Issue

Dec. 8, 2010

Vol. 111, No. 5


Alimta patent upheld

Published in the December 8, 2010, issue

A U.S. District Court judge on Nov. 15 upheld the patent for the cancer drug Alimta. The University holds the patent for Alimta, invented by chemistry professor emeritus Edward C. Taylor. Taylor developed the drug in collaboration with Eli Lilly and Co., which has an exclusive license for the patent, and Princeton receives royalties on sales of the drug.  

“Without Alimta, Princeton could not have constructed the splendid new Frick Hall, nor could it have attracted the stellar crop of junior and senior faculty members” who recently joined the chemistry department, said Provost Christopher Eisgruber ’83. He said the court’s ruling “not only recognizes the benefits that Ted Taylor's research has delivered to the world, but also makes it ­possible for Alimta revenues to underwrite future scientific discoveries at Princeton.”

Three generic drugmakers had challenged the patent, which protects Alimta until July 2016; Princeton and Lilly went to court to defend it. Lilly reported Alimta sales of $1.64 billion for the first nine months of 2010.

Post Comments
1 Response to Alimta patent upheld

Rhonda Zillig Says:

2012-04-30 09:59:18

I hope you're happy, Princeton University and Eli Lilly. While you're lining your pockets with money from Alimta, I will have to forgo my dream vacation to Europe for another year, that's providing I'm still alive. I have stage 4 lung cancer and never smoked.
Tell us what you think about
Alimta patent upheld
Enter the word as it appears in the picture below
By submitting a comment, you agree to PAW's comment posting policy.
CURRENT ISSUE: Dec. 8, 2010